Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study

OBJECTIVE: β-Cell autoantibodies are a feature of the preclinical phase of type 1 diabetes. Here, we asked how frequently they revert in a cohort of children at risk for type 1 diabetes and whether reversion has any effect on type 1 diabetes risk. RESEARCH DESIGN AND METHODS: Children were up to 10...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Care
Main Authors: Vehik, Kendra, Lynch, Kristian F., Schatz, Desmond A., Akolkar, Beena, Hagopian, William, Rewers, Marian, She, Jin-Xiong, Simell, Olli, Toppari, Jorma, Ziegler, Anette-G., Lernmark, Åke, Bonifacio, Ezio, Krischer, Jeffrey P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2016
Assuntos:
Epidemiology/Health Services Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5001144/
https://ncbi.nlm.nih.gov/pubmed/27311490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc16-0181
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados